Abstract
Retinal fluids, detectable through optical coherence tomography (OCT), are key biomarkers for retinal diseases such as diabetic macular edema and age-related macular degeneration, guiding treatment decisions and monitoring response to therapy. Automated segmentation of retinal fluids could support large-scale clinical research and the development of clinical decision support tools. Recent ophthalmic foundation models trained on massive retinal imaging datasets show promise across many downstream tasks, including disease risk prediction and biomarker segmentation, but their performance relative to task-specific models for specialized clinical tasks remains unclear. We compared a task-specific segmentation model (RetiFluidNet) and an ophthalmic foundation model (VisionFM) using a standard benchmarking dataset containing 4,248 OCT images from 48 patients with three retinal diseases. Models were evaluated using three-fold cross-validation and assessed for pixel-level segmentation accuracy and patient-level fluid burden estimation. The task-specific model achieved higher segmentation performance and more consistent fluid quantification across devices. These findings suggest that, for retinal fluid segmentation, specialized task-specific models currently remain more reliable than general-purpose foundation models, highlighting the need for targeted adaptation before clinical deployment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was partly supported by the National Library of Medicine (NLM) under Award Number R25LM014224.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study used publically available the MICCAI 2017 RETOUCH challenge dataset.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced can be requested from the organizers of the MICCAI 2017 RETOUCH challenge online at https://retouch.grand-challenge.org/.
